»ó´Ü¿©¹é
±â»ç (Àüü 817°Ç)
[Sub Story] ARB + CCB °íÇ÷¾Ð °ü¸® ÃÖÀûÀÇ º´¿ë¿ä¹ý ÀÓ¼¼Çü ±âÀÚ 2016-11-09 18:49
[Sub Story] Ç÷¾Ð º¯µ¿¼º, ½É³úÇ÷°üÁúȯ À§Çè ÁõÆø½ÃŲ´Ù ÀÓ¼¼Çü ±âÀÚ 2016-11-09 17:39
[Sub Story] Ç÷¾Ð º¯µ¿¼º °ü¸® À§ÇÑ ABPM¡¤HBPM ÀÓ¼¼Çü ±âÀÚ 2016-11-09 17:35
[Late Breaking Studies] HOPE-3 ¿¬±¸¿Í Ä­µ¥»ìź È¿°ú ÀÓ¼¼Çü ±âÀÚ 2016-11-09 17:04
[Hot Discussion] ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ RAS¾ïÁ¦Á¦ ¿ªÇÒ ÀÓ¼¼Çü ±âÀÚ 2016-11-09 17:01
¶óÀÎ
[Hot Discussion] Ç÷°üÈ®ÀåÈ¿°ú º£Å¸Â÷´ÜÁ¦ Ä«¸£º£µô·Ñ ÀÓ¼¼Çü ±âÀÚ 2016-11-09 16:58
[Conference Report] ERS 2016 ¿¬·ÊÇмú´ëȸ ÀÓ¼¼Çü ±âÀÚ 2016-11-09 16:51
[Cover Story] ½Å°æÁ¤½ÅÁúȯ ±¹°¡Â÷¿ø¿¡¼­ °ü¸®ÇÑ´Ù ÀÓ¼¼Çü ±âÀÚ 2016-10-31 17:15
[Sub Story] ¿µ±¹Á¤½Å¾à¹°ÇÐȸ Ç׿ì¿ïÁ¦ °¡À̵å¶óÀÎ ÀÓ¼¼Çü ±âÀÚ 2016-10-31 17:10
[Sub Story] 2¼¼´ë Ç׿ì¿ïÁ¦¡¤ºñ¾à¹°Ä¡·á ¾î¶»°Ô ½á¾ß Çϳª ÀÓ¼¼Çü ±âÀÚ 2016-10-31 17:07
¶óÀÎ
[Drug Review] ¼¼ÀÎÆ®Á¸½º¿öÆ®(St. John¡¯s wort) ÀÓ¼¼Çü ±âÀÚ 2016-10-31 17:04
[Interview] ¡°¿ì¿ïÁõ °ü¸® ¿ì¼±°úÁ¦´Â ¿©ÀüÈ÷ »çȸÀû ÀÎÁöµµ °³¼±¡± ÀÓ¼¼Çü ±âÀÚ 2016-10-31 17:03
[Sub Story] ±¹³» Ä¡¸ÅȯÀÚ ¿¬Æò±Õ 20% Áõ°¡ ÀÓ¼¼Çü ±âÀÚ 2016-10-31 16:59
[Deep in Guideline] È£ÁÖ NHMRC Ä¡¸Å °ü¸® °¡À̵å¶óÀÎ ÀÓ¼¼Çü ±âÀÚ 2016-10-31 16:52
[Drug Review] Äݸ° ¾ËÆ÷¼¼·¹ÀÌÆ® ÀÎÁö±â´ÉÀå¾Ö Ãʱ⿡¼­ Å« ÆøÀÇ °³¼±È¿°ú ÀÓ¼¼Çü ±âÀÚ 2016-10-28 18:25
¶óÀÎ
[Sub Story] ºÒ¾ÈÀå¾Ö¡¤Á¤½Åº´Áõ µ¿¹Ý ½Ã ¾à¹°¿ä¹ý ½ÅÁßÈ÷ °í·Á ÀÓ¼¼Çü ±âÀÚ 2016-10-28 18:22
[Drug Review] ºÎ½ºÇÇ·Ð ¾ÈÀü¼º ´ãº¸ÇÑ Ç׺ҾÈÈ¿°ú ÀÓ¼¼Çü ±âÀÚ 2016-10-28 18:16
[Interview] ¡°±¹³» Ä¡¸Å °ü¸®,¼±º°°Ë»ç ÇʵηΠÀü¹æÀ§Àü·« ¼ö¸³¡± ÀÓ¼¼Çü ±âÀÚ 2016-10-28 17:57
[Sub Story] ¿Ö ¼ö¸éÀå¾Ö °ü¸®¸¦ ¸»Çϳª ÀÓ¼¼Çü ±âÀÚ 2016-10-28 17:35
[Sub Story] ¹Ì±¹³»°úÇÐȸ ¸¸¼º ºÒ¸éÁõ °ü¸® °¡À̵å¶óÀÎ ÀÓ¼¼Çü ±âÀÚ 2016-10-28 17:31
Back to Top